Charles River Laboratories (24)

Browse by Contract Category

Contracts

Charles River Laboratories amended and restated Deferred Compensation Plan, as amended (Filed With SEC on May 4, 2021)
Agreement between David Ross Smith and Charles River Discovery Research Services UK Limited effective December 1, 2020 (Filed With SEC on May 4, 2021)
Ninth Amended and Restated Credit Agreement, dated as of April 21, 2021, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders... (Filed With SEC on April 23, 2021)
Form of Support Agreement (Filed With SEC on February 17, 2021)
Agreement and Plan of Merger, dated as of February 17, 2021, by and among Charles River Laboratories International, Inc., Memphis Merger Sub, Inc., Cognate BioServices, Inc. and... (Filed With SEC on February 17, 2021)
Executive Incentive Compensation Program effective January 1, 2021 (Filed With SEC on May 4, 2021)
First Supplemental Indenture, dated as of March 23, 2021, by and among the Company, the Guarantors and U.S. Bank National Association, as trustee (Filed With SEC on March 23, 2021)
Indenture, dated as of March 23, 2021, between the Company and U.S. Bank National Association, as trustee (Filed With SEC on March 23, 2021)
Agreement between David Smith and Charles River Laboratories, Inc. effective October 26, 2020 (Filed With SEC on November 9, 2020)
Agreement between David Smith and Charles River Laboratories, Inc. effective October 26, 2020 (Filed With SEC on October 29, 2020)
Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2018 Incentive Plan (Filed With SEC on August 5, 2020)
Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2018 Incentive Plan (Filed With SEC on August 5, 2020)
Charles River Laboratories International, Inc. Form of Non-Qualified Stock Option granted under the 2018 Incentive Plan (Filed With SEC on August 5, 2020)
Charles River Laboratories International, Inc. Amended and Restated 2018 Incentive Plan, dated May 6, 2020 (Filed With SEC on May 7, 2020)
Description of Securities (Filed With SEC on February 11, 2020)
Charles River Laboratories International, Inc. Third Amendment dated November 4, 2019 relating to the Eighth Amended and Restated Credit Agreement dated March 26, 2018 (Filed With SEC on November 6, 2019)
Charles River Laboratories International, Inc. Second Amendment dated September 25, 2019 relating to the Eighth Amended and Restated Credit Agreement dated March 26, 2018 (Filed With SEC on November 6, 2019)
Agreement between David Johst and Charles River Laboratories, Inc. effective July 26, 2019 (Filed With SEC on November 6, 2019)
Second Supplemental Indenture, dated as of October 23, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (Filed With SEC on October 23, 2019)
Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2018 Incentive Plan (Filed With SEC on July 31, 2019)
Charles River Laboratories International, Inc. Form of Non-Qualified Stock Option granted under the 2018 Incentive Plan (Filed With SEC on July 31, 2019)
Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2018 Incentive Plan (Filed With SEC on July 31, 2019)
Exclusivity Agreement among CTL International SAS. (CTL) among Charles River Nederland B.V., Charles River Laboratories International, Inc. (as guarantor). AXO LBO Fund V... (Filed With SEC on February 15, 2019)
Offer relating to CTL International SAS. (CTL) among Charles River Nederland B.V., Charles River Laboratories International, Inc. (as guarantor). AXO LBO Fund V Supplementary... (Filed With SEC on February 15, 2019)